Active Cross-Linking
Crossing, an innovative startup based in Italy, is developing a new class of “Active Cross-Linking Agents” (ACLs) at competitive prices. ACLs can be applied in various fields due to their unique ability to bind different molecules using a “lock and key” mechanism similar to enzymes. The structures of ACLs are highly adaptable, allowing the creation of a diverse chemical library with varying properties such as activity, speed of action, performance, and industrial applications.